Clinical Trial Update: Anastrozole or Tamoxifen in Treating Postmenopausal Women With Ductal Carcinoma in Situ Who Are Undergoing Lumpectomy and Radiation Therapy [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating anastrozole or tamoxifen in postmenopausal women with ductal carcinoma in situ undergoing lumpectomy and radiation therapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Ductal Carcinoma in Situ

Drugs mentioned

• Anastrozole (Anastrozole)
• Tamoxifen (tamoxifen)

Snippet

Sponsor: NSABP Foundation Inc | Conditions: Breast Cancer | Phase 3 | Status: COMPLETED | Results posted: 2018-03-12